CL King
http://www.clking.com/CL King is a self-clearing and service-oriented boutique which provides investment research, equity and fixed income trading, prime brokerage, registered investment advising and correspondent clearing services. The firm offers their services to institutional investors, high net worth individuals, and broker dealers. CL King was founded in 1972 and became self-clearing in 1983.
View Older Stories View More Recent Stories
-
Fluidigm to Participate at Upcoming Investor Events in September
-
Denny’s Corporation to Present at CL King’s 16th Annual Best Ideas Conference on September 13, 2018
-
Hyster-Yale Materials Handling, Inc. To Participate In CL King's 2018 Best Ideas Conference
-
Dine Brands Global, Inc. to Present at CL King's 16th Annual Best Ideas Conference
-
RBC Bearings to Participate in CL King’s 16th Annual Best Ideas Conference
-
ABM Industries to Participate in CL King’s 16th Annual Best Ideas Conference on September 13
-
AMERCO to Participate in CL King's Best Ideas Conference 2018
-
LKQ Corporation to Present at Upcoming Investor Conferences
-
Kindred Biosciences to Participate in the CL King 16th Annual Best Ideas Conference, Lake Street Capital Markets 2nd Annual Best Ideas Growth Conference and LD Micro San Francisco Summit
-
Heska to Hold One-on-One Meetings at CL King's 16th Annual Best Ideas Conference 2018 on September 13, 2018
-
SP Plus Corporation Announces Participation in the CL King & Associates 16th Annual Best Ideas Conference
-
Aratana Therapeutics to Present at CL King and Associates Best Ideas Conference
-
Codexis to Present at Three Investment Conferences in September
-
Merit Medical to Present at Three Upcoming Conferences
-
Invacare Corporation to Present at September 2018 Conferences
-
Noodles & Company to Participate at the CL King’s 16th Annual Best Ideas Conference
-
CL King Downgrades Lancaster Colony (LANC) to Neutral Citing Valuation
-
Invacare Reports Results for Second Quarter 2018
-
UPDATE: CL King Downgrades Pinnacle Foods (PF) to Neutral Citing Limited Upside to the Current Valuation
-
Central Garden & Pet Co. (CENT) PT Raised to $48 at CL King
-
Deluxe Reports Second Quarter 2018 Financial Results
-
Papa John's (PZZA) Likely Worth $65 Per Share in Rumored Wendy's (WEN) Deal Talks - CL King
-
Dorman Products (DORM) Remains a Top Pick for 2018 at CL King
-
CL King Upgrades Wolverine World Wide (WWW) to Strong Buy as 'Transformational Benefits Abound'
-
CL King Downgrades Standard Motor Products, Inc. (SMP) to Neutral Citing Valuation
-
CL King Upgrades Kindred Biosciences (KIN) to Buy, Says Recent Survey indicates 'Overwhelming' Interest in Mirataz
-
Lancaster Colony (LANC) PT Raised to Street High $150 at CL King
-
CL King Starts Welbilt, Inc. (WBT) at Neutral Citing Vluation and Leverage Levels
-
CL King Starts Timken (TKR) at Neutral, Expects Shares to Remain Range-Bound
-
Trupanion Announces Closing of $69 Million Public Offering of Common Stock and Exercise in Full of Underwriters’ Over-Allotment Option
-
Repligen (RGEN) PT Raised to $50 at CL King
-
Trupanion (TRUP) Prices 1.82M Share Offering of Common Stock at $33/Sh
-
Trupanion Announces Pricing of $60 Million Public Offering of Common Stock
-
UPDATE: CL King Starts PetMed Express (PETS) at Neutral Says Don't Under-Estimate Co. or Competition
-
CL King Starts Noodles & Co. (NDLS) at Buy
-
Quidel Corp. (QDEL) PT Raised to $67 at CL King
-
CL King Downgrades Genesco (GCO) to Neutral
-
Quidel Corp. (QDEL) PT Raised to $62 at CL King
-
IDEXX Laboratories (IDXX) PT Raised to $230 at CL King; 'Already Robust Growth is Accelerating'
-
UPDATE: CL King Starts G-III Apparel (GIII) at Buy
-
Denny's Corporation (DENN) PT Raised to $19 at CL King
-
CL King Downgrades Columbia Sportswear (COLM) to Neutral
-
CL King Downgrades Bojangles' (BOJA) to Neutral, Says 'Risk/Reward Now Balanced'
-
CL King Starts Stoneridge (SRI) at Buy, Says Intnerational Business is Expecting Meaningful P/E Multiple Expansion'
-
UPDATE: CL King Reinitiates AMERCO (UHAL) at Neutral
-
Quidel Corp. (QDEL) PT Raised to $60 at CL King
-
CL King Downgrades Axon Enterprise, Inc. (AAXN) to Neutral
-
CL King Upgrades Aratana Therapeutics (PETX) to Buy Citing Enticing Risk/Reward
-
CL King Upgrades Brunswick Corp (BC) to Buy Citing Benefits From Fitness Business Spin-Off
-
CL King Downgrades Bio-Rad Labs (BIO) to Neutral, 'Margin Expansion Playing Out; Next Leg Up Likely Slower'

